U.S., Nov. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07245875) titled 'Umbilical Cord Mesenchymal Stem Cell Secretome Administration in Severe Erectile Dysfunction Non-responsive to Sildenafil' on Aug. 03.

Brief Summary: The study is an experimental pre-post-test design involving 12 patients with severe ED non-responsive to sildenafil. Safety parameters included pain, hematoma, local bleeding, and infection, while efficacy was measured using the IIEF-5 questionnaire, EHS, and morning erection.

Study Start Date: April 12, 2024

Study Type: INTERVENTIONAL

Condition: Erectile Dysfunction Diabetes Mellitus Type 2

Intervention: BIOLOGICAL: Intracavernosal Injection of Umbilical Cord Mesenchymal Stem Ce...